Nanotechnology Now - Press Release: Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016

Home > Press > Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016

Abstract:
Harris & Harris Group, Inc. (NASDAQ:TINY), announced today that it will hold a conference call to update shareholders, analysts and interested attendees on its business and to answer questions, on Tuesday, August 23, 2016, at 10:00 a.m. Eastern Time.

Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016

New York, NY | Posted on August 16th, 2016

Additionally, one of Harris & Harris Group's precision health and medicine portfolio companies, Muses Labs, Inc., will present during the call. Muses Labs employs data to identify the underlying causes of chronic diseases, develop an evidence-based, personalized combination therapy, and work collaboratively with patients, caregivers, and health care providers to improve outcomes. More information on Muses Labs can be found on its website at www.museslabs.com.

What: Harris & Harris Group Second Quarter 2016 Shareholder Update and Muses Labs Presentation Conference Call and Webcast

When: Tuesday, August 23, 2016

Time: 10:00 a.m. (ET)

Live Call: (877) 303-9855, domestic
(408) 337-0154, international

Webcast: http://ir.hhvc.com/events.cfm

Please access the site at least 15 minutes prior to the scheduled start time in order to download any audio software that may be required. A replay of the webcast will be accessible through the Company's website for seven days following the live event. For those unable to listen to the call via the Internet, a replay of the call will be available until 1 p.m. Eastern Time on Tuesday, August 30, 2016, by dialing (404) 537-3406. The conference ID for the replay is 51635129.

####

About Harris & Harris Group
Harris & Harris Group is a publicly traded, internally managed business development company that builds transformative companies from disruptive science. Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com, on Facebook at www.facebook.com/harrisharrisvc and by following on Twitter @harrisandharrisgroup.

This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including, but not limited to, the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The references to the websites www.HHVC.com, www.museslabs.com and www.Facebook.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Harris & Harris Group is not responsible for the contents of third party websites.

For more information, please click here

Contacts:
Daniel B. Wolfe
Harris & Harris Group, Inc.
Chief Executive Officer
(212) 582-0900

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: